605507 Guobang Pharma Ltd.
- 17.37
- -0.20-1.14%
Guobang Pharma Ltd. News
Announcement on Shareholding Reduction Plan and Results at the Expiration of the Plan Period of National United Medical Co., Ltd.'s Shareholders.
Announcement on the Progress of Guobang Pharmaceutical's Repurchase of Shares through Centralized Competitive Trading.
Announcement on the Progress of Guobang Pharmaceutical's Repurchase of Shares through Centralized Competitive Trading.
Announcement of the implementation of annual equity distribution of Guobang Pharmaceutical in 2023.
Guobang Pharmaceutical's progress announcement on the repurchase of shares through centralized bidding
Guobang Pharmaceutical's announcement on adjusting the distribution amount per share of the 2023 profit distribution plan
Guobang Pharmaceutical's announcement on the repurchase ratio of the company's shares reached 1% through centralized bidding transactions and the progress of the repurchase
Guobang Pharmaceutical's indicative announcement on the progress of shareholders' reduction in shareholders' holdings and changes in equity of more than 1%
Guobang Pharmaceutical's progress announcement on the repurchase of shares through centralized bidding
Guobang Pharmaceutical's indicative announcement on changes in shareholders' rights
Simplified equity change report (Zhejiang Investment Henghua, Silk Road Fund)
Guobang Pharmaceutical Announces Plans to Reduce Shareholdings by Shareholders Holding 5% or More of Their Shares
Guobang Pharmaceutical's announcement on the results of shareholding reduction results for shareholders holding 5% or more of the shares
Simplified equity change report (Zhejiang Investment Henghua, Silk Road Fund)
Guobang Pharmaceutical's indicative announcement on changes in shareholders' equity reaching 5%
Guobang Pharmaceutical\'s announcement on the 2023 profit distribution plan
Guobang Pharmaceutical's progress announcement on the repurchase of shares through centralized bidding
Guobang Pharmaceutical's indicative announcement on shareholders holding 5% or more of shares reducing their shareholding by more than 1%
Guobang Pharmaceutical's announcement on progress in reducing shareholdings by shareholders holding 5% or more of their shares
Guobang Pharmaceutical's progress announcement on the repurchase of shares through centralized bidding
Analysis
Price Target
No Data
